Industrial and Manufacturing
While the industrial and manufacturing sector is large and diverse, most of its players face similar challenges.
Unless offset by price and surcharge rises, margins have been squeezed by the rising costs of oil, natural gas and steel. At the same time, customers are reluctant to invest in new equipment and the demand for after sales services has grown.
To strengthen core product lines or expand their presence geographically, some players are looking to acquire, while others are keen to divest their under-performing businesses. This comes at a time when local and national taxes, often managed across many territories, are more and more complex and under constant review.
We have a global understanding of the sector and so are ideally placed to share and apply the market intelligence and legal know-how we’ve gained from working in key markets and multiple jurisdictions. Consequently, our advice is realistic, practical and commercially viable.
Meet our lawyers
News & insights
Publications: 18 MAY 2020
Beyond Covid-19: Reinvigorating the economy in the MENA region by focusing on mid-caps and SMEs
The Covid-19 pandemic has taken its toll on the community of mid-caps and small and medium-sized enterprises (SMEs) that play an important role in supporting the economy in the Middle East and North…
Read more
Publications: 11 DECEMBER 2019
Australia proposes robust new foreign bribery laws
On Monday 2 December, the Australian Government introduced into the Senate the Crimes Legislation Amendment (Combatting Corporate Crime) Bill 2019 (Cth) (“Foreign Bribery Bill”). This Bill proposes to…
Read more
Publications: 04 OCTOBER 2019
Outstanding performance by A&O in global M&A league tables
A&O has marked the end of Q3 2019 with an outstanding performance in the M&A league tables; the result of advising on a number of complex, high-value transactions in a wide range of sectors and…
Read more
Publications: 28 AUGUST 2019
NICE consults on Draft Guideline on prescribing medicinal cannabis
On 8 August 2019, the National Institute for Health and Care Excellence (NICE)1 published a draft guideline on prescribing cannabis-based medicinal products (the Draft Guideline) for consultation.2
Read more